Trials / Not Yet Recruiting
Not Yet RecruitingNCT07507838
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules in Chinese Healthy Participants
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Vigonvita Life Sciences · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation trial to assess the safety, tolerability, pharmacokinetics （PK） of multiple doses of VV913 in Chinese healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VV913 4mg group | 6 participants will receive VV913 4mg orally; 2 participants will receive placebo orally. |
| DRUG | VV913 8mg group | 6 participants will receive VV913 8mg orally; 2 participants will receive placebo orally. |
| DRUG | VV913 15mg group | 6 participants will receive VV913 15mg orally; 2 participants will receive placebo orally. |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2026-04-02
- Last updated
- 2026-04-02
Source: ClinicalTrials.gov record NCT07507838. Inclusion in this directory is not an endorsement.